Long-Half-Life Thiazide-Like Distal Convoluted Tubule Diuretic • Rx

Chlorthalidone

Brand Reference: Thalitone

Medically Reviewed by Dr. Marcus Thorne, MD, FACC (NPI #1184629314)
84.20%
Patient “Worth It”
15 verified logs
$7.40
Lowest Monthly Cash

Chlorthalidone Clinical & Real-World Cost Fact Matrix

Metric Verified Benchmark Source
Chlorthalidone RxNorm Concept ID 2409 U.S. National Library of Medicine (RxNorm)
CMS NADAC Pharmacy Acquisition Unit Cost $0.1320 / unit CMS Medicaid NADAC Weekly Feed
Walk-In Chain Pharmacy Cash Average $39.00 / mo CMS NADAC + U.S. Retail Markup Index
Mark Cuban Cost Plus Wholesale Price $7.40 / mo Cost Plus Drugs Wholesale Feed
Community Mean Out-of-Pocket Paid $8.90 / mo 15 Zero-PHI Verified Patient Logs
INSTANT PRESCRIPTION & CASH ROUTING

Verified Online Prescribers & Wholesale Pharmacies for Chlorthalidone

DotMD Club Members get $29 flat-rate script renewals →
Mark Cuban Cost Plus Drugs (Wholesale Pharmacy)
Requires an existing doctor prescription. Need a script? Pair with a $29 DotMD Club TeleMed consult.
$7.40/mo
Wholesale Cash Price
View Wholesale Rx →
Sesame Direct Cash-Pay Prescriber Network (Online Doctor Consult + Delivery)
Asynchronous physician review included • Ships in ~1 days
$ 29.00
Consult / Starting Tier
Start Online Visit →

Chlorthalidone Clinical Pharmacology & DailyMed Monograph

RxCUI 2409 • NDC 00378-1125-01

Inhibits Na+/Cl- symporters in the cortical diluting segment of the distal convoluted tubule while sequestering in erythrocyte carbonic anhydrase reservoirs—delivering 48-to-72-hour nocturnal blood pressure control superior to short-acting hydrochlorothiazide.

Classified under Long-Half-Life Thiazide-Like Distal Convoluted Tubule Diuretic (Rx), Chlorthalidone exhibits a $31.60/month gap between standard U.S. retail cash counters ($39.00) and verified direct-to-patient routing ($7.40) anchored to $0.1320 CMS unit cost.

Pharmacokinetic profiling of Chlorthalidone demonstrates an elimination half-life of 40–60 hours with 64% oral systemic bioavailability; clearance proceeds via 65% excreted unchanged renally; sequestered 70:1 inside red blood cells, reaching clinical onset within 2.6 hours natriuretic onset.

Titration schedules for Chlorthalidone (12.5 mg PO QAM → 25 mg PO QAM) require excluding anuria; severe refractory hyponatremia or hypokalemia; sulfonamide anaphylaxis; real-world patient logs highlight potassium -0.3 meq/l (16% of reports), morning urination (14% of reports), uric acid elevation (11% of reports) alongside a 84.20% Worth-It consensus.

Half-Life
40–60 hours
Bioavailability
64% oral
Metabolism & Clearance
65% excreted unchanged renally; sequestered 70:1 inside red blood cells
Clinical Onset
2.6 hours natriuretic onset

Standard Adult Titration & Dosages

12.5 mg PO QAM 25 mg PO QAM

Absolute & Relative Contraindications

  • Anuria
  • Severe refractory hyponatremia or hypokalemia
  • Sulfonamide anaphylaxis

Logged Side-Effect Incidence (15 Reports)

Potassium -0.3 mEq/L 16%
Morning urination 14%
Uric acid elevation 11%

Chlorthalidone Patient Dosage Logs & Out-of-Pocket Cost Ledger

Across 15 verified cash-pay logs, Chlorthalidone achieves a 84.20% Worth-It rating with out-of-pocket spend averaging $8.90/mo versus $39.00/mo walk-in retail.

15-Second Anonymous Micro-Log (Zero-PHI Architecture)

Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.

Effectiveness: 5/5 • Worth It Dosage: 12.5 mg PO QAM • Paid: $6.51/mo via Cost Plus Drugs
Potassium -0.3 mEq/L

Switched to Cost Plus Drugs at 12.5 mg PO QAM for Chlorthalidone; monthly out-of-pocket dropped to $6.51 compared with $39.00 retail.

Effectiveness: 5/5 • Worth It Dosage: 25 mg PO QAM • Paid: $7.55/mo via Cost Plus Drugs

Completed 10 weeks on Chlorthalidone (25 mg PO QAM). Zero notable side effects on steady dosing.

Effectiveness: 4/5 • Worth It Dosage: 12.5 mg PO QAM • Paid: $8.58/mo via Local Pharmacy
Morning urination

Consistent biomarker response on 12.5 mg PO QAM Chlorthalidone sourced via Local Pharmacy ($8.58/mo cash pay without insurance prior authorization).